Intensive prostate cancer treatments may not yield benefits for older patients with comorbidities, according to a study in the Annals of Internal Medicine. Surgery and radiation may not improve survival in such patients, and the treatments may affect quality of life. "The key point is that when men are choosing therapy for prostate cancer, they need to consider their tumor characteristics, their age and other characteristics," said senior author Dr. David Penson.
Intensive therapies may not benefit older prostate cancer patients
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||